Core Laboratories N.V. (CLB) is Reiterated by Cowen to Market Perform, Raises Price Target to $ 105

Core Laboratories N.V. (CLB) was Reiterated by Cowen to “Market Perform” according to the research note released today. The brokerage firm has raised the Price Target to $ 105 from a previous price target of $80 . Cowen advised their investors in a research report released on Apr 22, 2016.

Many Wall Street Analysts have commented on Core Laboratories N.V.. Core Laboratories N.V. was Initiated by Citigroup to “Neutral” on Feb 29, 2016. Shares were Reiterated by Scotia Howard Weil on Jan 29, 2016 to “Sector Perform” and Lowered the Price Target to $ 105 from a previous price target of $117 .Shares were Reiterated by RBC Capital Mkts on Jan 28, 2016 to “Outperform” and Lowered the Price Target to $ 105 from a previous price target of $130 .

On the company’s financial health, Core Laboratories N.V. reported $0.37 EPS for the quarter, based on the information available during the earnings call on Apr 20, 2016. Analyst had a consensus estimate of $0.37. The company had revenue of $153.65 million for the quarter, compared to analysts expectations of $156.67 million. The company’s revenue was down -28.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.86 EPS.

Core Laboratories N.V. opened for trading at $119.39 and hit $127.96 on the upside on Wednesday, eventually ending the session at $124.78, with a gain of 5.13% or 6.09 points. The heightened volatility saw the trading volume jump to 12,54,542 shares. Company has a market cap of $5,288 M.

In a different news, on Feb 3, 2016, Jan Willem Sodderland (director) purchased 300 shares at $93.90 per share price. According to the SEC, on May 13, 2015, Michael C Kearney (director) sold 1,000 shares at $128.52 per share price. On Feb 3, 2015, Kempen Margaret Ann Van (director) purchased 250 shares at $102.07 per share price, according to the Form-4 filing with the securities and exchange commission.

Core Laboratories N.V. (Core Lab) is a provider of proprietary and patented reservoir description production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.

Core Laboratories N.V.

Leave a Reply

Core Laboratories N.V. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Core Laboratories N.V.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.